Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411

Share on StockTwits

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan experts present strategic insights on key trends such as virtual care, vaccines, hospital efficiency solutions, digital biomarkers, and microbiome therapeutics


Santa Clara, Calif. - January 8, 2021 ( Newswire) Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving but transformational year for the healthcare industry. The industry growth overall dropped from 3.5% in 2019 to 1.8% in 2020. However, some market sectors have grown faster than expected, and several trends have been accelerated, shifting opportunities in the market. The healthcare industry is moving towards smarter, precision, predictive and personalized care, beyond the hospital and clinic walls.

Healthcare technologies are leading a global transformation. There is a significant spike of innovations fueling transformative vaccine strategies and increased use of digital technologies such as intelligent imaging analysis and virtual care to drive novel preventive healthcare and treatment strategies. To help companies identify new avenues for top-line growth and plan for a more fruitful 2021, Frost & Sullivan’s team of industry experts have compiled a complimentary insight: Top 8 Growth Opportunities in the Healthcare and Life Sciences Industry for 2021 – What You Need to Know Now.

To download the complimentary insight, please visit:

Gain insight into exciting new growth opportunities, strategic recommendations, best practices, and future developments in the following areas:

  1. Transformative Vaccines
  2. Virtual Care
  3. Artificial Intelligence-based Medical Imaging
  4. Hospital Efficiency Solutions
  5. Digital Biomarkers
  6. Microbiome Therapeutics
  7. Combination Immuno-oncology (I-O) Therapies
  8. Laboratory Information Management Solutions (LIMS)

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion


Mariana Fernandez
Corporate Communications
P: +1 (210) 348.1012

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits - A Leading Global Investor Website for Biotech Industry Stocks - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on